Responses
Poster Presentations
Psoriatic arthritis
SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis
Compose a Response to This Article
Other responses
No responses have been published for this article.